The current emphasis on the dark side of Nrf2 is mostly focused on the Nrf2 signaling in the tumor cells, whereas the possible impact of Nrf2 on the behavior of tumor-associated immune cells, macrophages and fibroblast cells is unexplored. The gene discussed is NFE2L2; the disease is neoplasm.